Advertisement

Whole exome sequencing identifies a novel SCN1A mutation in genetic (idiopathic) generalized epilepsy and juvenile myoclonic epilepsy subtypes

  • Chung-Kin Chan
  • Joyce Siew-Yong Low
  • Kheng-Seang LimEmail author
  • Siew-Kee Low
  • Chong-Tin Tan
  • Ching-Ching NgEmail author
Original Article
  • 67 Downloads

Abstract

Introduction

Genetic (idiopathic) generalized epilepsy (GGE) is a common form of epilepsy characterized by unknown aetiology and a presence of genetic component in its predisposition.

Methods

To understand the genetic factor in a family with GGE, we performed whole exome sequencing (WES) on a trio of a juvenile myoclonic epilepsy/febrile seizure (JME/FS) proband with JME/FS mother and healthy father. Sanger sequencing was carried out for validation of WES results and variant detection in other family members.

Results

Predictably damaging variant found in affected proband and mother but absent in healthy father in SCN1A gene was found to be associated with generalized epilepsy and febrile seizure. The novel non-synonymous substitution (c.5753C>T, p.S1918F) in SCN1A was found in all family members with GGE, of which 4/8 were JME subtypes, and/or febrile seizure, while 3 healthy family member controls did not have the mutation. This mutation was also absent in 41 GGE patients and 414 healthy Malaysian Chinese controls.

Conclusion

The mutation is likely to affect interaction between the sodium channel and calmodulin and subsequently interrupt calmodulin-dependent modulation of the channel.

Keywords

SCN1A Juvenile myoclonic epilepsy (JME) Genetic generalized epilepsy (GGE) Febrile seizure (FS) 

Notes

Acknowledgments

We are grateful to the affected family and all individuals participating in this study.

Funding information

This research is supported by High Impact Research MOHE Grant (UM.C/625/1/HIR/MOHE/MED/45) from the Ministry of Higher Education Malaysia.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Informed consent

This study was approved by the Medical Ethics Committee of University Malaya Medical Centre (MEC reference number: 944.3). Written consent was obtained from all subjects.

Supplementary material

10072_2019_4122_MOESM1_ESM.pdf (108 kb)
ESM 1 Summary of whole exome sequencing quality control (PDF 108 kb)
10072_2019_4122_MOESM2_ESM.pdf (140 kb)
ESM 2 Protein alignments of Nav 1.1 demonstrate high homology of amino acid residue p.Ser1918 (shown in red box) across a set of divergent species (PDF 140 kb)

References

  1. 1.
    Lucarini N, Verrotti A, Napolioni V, Bosco G, Curatolo P (2007) Genetic polymorphisms and idiopathic generalized epilepsies. Pediatr Neurol 37(3):157–164.  https://doi.org/10.1016/j.pediatrneurol.2007.06.001 CrossRefPubMedGoogle Scholar
  2. 2.
    Fjaer R, Brodtkorb E, Oye AM, Sheng Y, Vigeland MD, Kvistad KA, Backe PH, Selmer KK (2015) Generalized epilepsy in a family with basal ganglia calcifications and mutations in SLC20A2 and CHRNB2. Eur J Med Genet 58(11):624–628.  https://doi.org/10.1016/j.ejmg.2015.10.005 CrossRefPubMedGoogle Scholar
  3. 3.
    Liu XW, Li W, Han T, Wei K, Qiao S, Su L, Chi Z (2018) The finding of a new heterozygous mutation site of the SCN2A gene in a monozygotic twin family carrying and exhibiting genetic epilepsy with febrile seizures plus (GEFS+) using targeted next-generation sequencing. Clin Neurol Neurosurg 169:86–91.  https://doi.org/10.1016/j.clineuro.2017.10.020 CrossRefPubMedGoogle Scholar
  4. 4.
    Parihar R, Ganesh S (2013) The SCN1A gene variants and epileptic encephalopathies. J Hum Genet 58(9):573–580.  https://doi.org/10.1038/jhg.2013.77 CrossRefPubMedGoogle Scholar
  5. 5.
    Binini N, Sancini G, Villa C, Dal Magro R, Sansoni V, Rusconi R, Mantegazza M, Grioni D, Talpo F, Toselli M, Combi R (2017) Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE). Brain Res 1677:26–32.  https://doi.org/10.1016/j.brainres.2017.09.023 CrossRefPubMedGoogle Scholar
  6. 6.
    Thounaojam R, Langbang L, Itisham K, Sobhani R, Srivastava S, Ramanujam B, Verma R, Tripathi M, Aguan K (2017) EFHC1 mutation in Indian juvenile myoclonic epilepsy patient. Epilepsia Open 2(1):84–89.  https://doi.org/10.1002/epi4.12037 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Phani NM, Acharya S, Xavy S, Bhaskaranand N, Bhat MK, Jain A, Rai PS, Satyamoorthy K (2014) Genetic association of KCNJ10 rs1130183 with seizure susceptibility and computational analysis of deleterious non-synonymous SNPs of KCNJ10 gene. Gene 536(2):247–253.  https://doi.org/10.1016/j.gene.2013.12.026 CrossRefPubMedGoogle Scholar
  8. 8.
    Kahle KT, Merner ND, Friedel P, Silayeva L, Liang B, Khanna A, Shang Y, Lachance-Touchette P, Bourassa C, Levert A, Dion PA, Walcott B, Spiegelman D, Dionne-Laporte A, Hodgkinson A, Awadalla P, Nikbakht H, Majewski J, Cossette P, Deeb TZ, Moss SJ, Medina I, Rouleau GA (2014) Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy. EMBO Rep 15(7):766–774.  https://doi.org/10.15252/embr.201438840 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Striano P, Weber YG, Toliat MR, Schubert J, Leu C, Chaimana R, Baulac S, Guerrero R, LeGuern E, Lehesjoki AE, Polvi A, Robbiano A, Serratosa JM, Guerrini R, Nurnberg P, Sander T, Zara F, Lerche H, Marini C, Consortium E (2012) GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology 78(8):557–562.  https://doi.org/10.1212/WNL.0b013e318247ff54 CrossRefPubMedGoogle Scholar
  10. 10.
    Jiang Y, Zhang Y, Zhang P, Sang T, Zhang F, Ji T, Huang Q, Xie H, Du R, Cai B, Zhao H, Wang J, Wu Y, Wu H, Xu K, Liu X, Chan P, Wu X (2012) NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet 131(7):1217–1224.  https://doi.org/10.1007/s00439-012-1149-3 CrossRefPubMedGoogle Scholar
  11. 11.
    Neubauer BA, Waldegger S, Heinzinger J, Hahn A, Kurlemann G, Fiedler B, Eberhard F, Muhle H, Stephani U, Garkisch S, Eeg-Olofsson O, Muller U, Sander T (2008) KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. Neurology 71(3):177–183.  https://doi.org/10.1212/01.wnl.0000317090.92185.ec CrossRefPubMedGoogle Scholar
  12. 12.
    Lachance-Touchette P, Martin C, Poulin C, Gravel M, Carmant L, Cossette P (2010) Screening of GABRB3 in French-Canadian families with idiopathic generalized epilepsy. Epilepsia 51(9):1894–1897.  https://doi.org/10.1111/j.1528-1167.2010.02642.x CrossRefPubMedGoogle Scholar
  13. 13.
    Saint-Martin C, Gauvain G, Teodorescu G, Gourfinkel-An I, Fedirko E, Weber YG, Maljevic S, Ernst JP, Garcia-Olivares J, Fahlke C, Nabbout R, LeGuern E, Lerche H, Poncer JC, Depienne C (2009) Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy. Hum Mutat 30(3):397–405.  https://doi.org/10.1002/humu.20876 CrossRefPubMedGoogle Scholar
  14. 14.
    Singh B, Monteil A, Bidaud I, Sugimoto Y, Suzuki T, Hamano S, Oguni H, Osawa M, Alonso ME, Delgado-Escueta AV, Inoue Y, Yasui-Furukori N, Kaneko S, Lory P, Yamakawa K (2007) Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online. Hum Mutat 28(5):524–525.  https://doi.org/10.1002/humu.9491 CrossRefPubMedGoogle Scholar
  15. 15.
    Marini C, Porro A, Rastetter A, Dalle C, Rivolta I, Bauer D, Oegema R, Nava C, Parrini E, Mei D, Mercer C, Dhamija R, Chambers C, Coubes C, Thevenon J, Kuentz P, Julia S, Pasquier L, Dubourg C, Carre W, Rosati A, Melani F, Pisano T, Giardino M, Innes AM, Alembik Y, Scheidecker S, Santos M, Figueiroa S, Garrido C, Fusco C, Frattini D, Spagnoli C, Binda A, Granata T, Ragona F, Freri E, Franceschetti S, Canafoglia L, Castellotti B, Gellera C, Milanesi R, Mancardi MM, Clark DR, Kok F, Helbig KL, Ichikawa S, Sadler L, Neupauerova J, Lassuthova P, Sterbova K, Laridon A, Brilstra E, Koeleman B, Lemke JR, Zara F, Striano P, Soblet J, Smits G, Deconinck N, Barbuti A, DiFrancesco D, LeGuern E, Guerrini R, Santoro B, Hamacher K, Thiel G, Moroni A, DiFrancesco JC, Depienne C (2018) HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond. Brain 141(11):3160–3178.  https://doi.org/10.1093/brain/awy263 CrossRefPubMedGoogle Scholar
  16. 16.
    Epi25 Collaborative. Electronic address sbuea, Epi C (2019) Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals. Am J Hum Genet 105(2):267–282.  https://doi.org/10.1016/j.ajhg.2019.05.020 CrossRefGoogle Scholar
  17. 17.
    Yang C, Hua Y, Zhang W, Xu J, Xu L, Gao F, Jiang P (2018) Variable epilepsy phenotypes associated with heterozygous mutation in the SCN9A gene: report of two cases. Neurol Sci 39(6):1113–1115.  https://doi.org/10.1007/s10072-018-3300-y CrossRefPubMedGoogle Scholar
  18. 18.
    Heinzen EL, Depondt C, Cavalleri GL, Ruzzo EK, Walley NM, Need AC, Ge D, He M, Cirulli ET, Zhao Q, Cronin KD, Gumbs CE, Campbell CR, Hong LK, Maia JM, Shianna KV, McCormack M, Radtke RA, O’Conner GD, Mikati MA, Gallentine WB, Husain AM, Sinha SR, Chinthapalli K, Puranam RS, McNamara JO, Ottman R, Sisodiya SM, Delanty N, Goldstein DB (2012) Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 91(2):293–302.  https://doi.org/10.1016/j.ajhg.2012.06.016 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Chen ZH, Wang C, Zhuo MQ, Zhai QX, Chen Q, Guo YX, Zhang YX, Gui J, Tang ZH, Zeng XL (2017) Exome sequencing identified a novel missense mutation c.464G>A (p.G155D) in Ca(2+)-binding protein 4 (CABP4) in a Chinese pedigree with autosomal dominant nocturnal frontal lobe epilepsy. Oncotarget 8(45):78940–78947.  https://doi.org/10.18632/oncotarget.20694 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Carvill GL, Weckhuysen S, McMahon JM, Hartmann C, Moller RS, Hjalgrim H, Cook J, Geraghty E, O'Roak BJ, Petrou S, Clarke A, Gill D, Sadleir LG, Muhle H, von Spiczak S, Nikanorova M, Hodgson BL, Gazina EV, Suls A, Shendure J, Dibbens LM, De Jonghe P, Helbig I, Berkovic SF, Scheffer IE, Mefford HC (2014) GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 82(14):1245–1253.  https://doi.org/10.1212/WNL.0000000000000291 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Zeng Q, Yang X, Zhang J, Liu A, Yang Z, Liu X, Wu Y, Wu X, Wei L, Zhang Y (2018) Genetic analysis of benign familial epilepsies in the first year of life in a Chinese cohort. J Hum Genet 63(1):9–18.  https://doi.org/10.1038/s10038-017-0359-x CrossRefPubMedGoogle Scholar
  22. 22.
    Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754–1760.  https://doi.org/10.1093/bioinformatics/btp324 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Genome Project Data Processing S (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25(16):2078–2079.  https://doi.org/10.1093/bioinformatics/btp352 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498.  https://doi.org/10.1038/ng.806 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886–D894.  https://doi.org/10.1093/nar/gky1016 CrossRefPubMedGoogle Scholar
  26. 26.
    Quang D, Chen Y, Xie X (2015) DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31(5):761–763.  https://doi.org/10.1093/bioinformatics/btu703 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081.  https://doi.org/10.1038/nprot.2009.86 CrossRefPubMedGoogle Scholar
  28. 28.
    Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249.  https://doi.org/10.1038/nmeth0410-248 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7(10):e46688.  https://doi.org/10.1371/journal.pone.0046688 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424.  https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33(Web Server issue):W306–W310.  https://doi.org/10.1093/nar/gki375 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372(3):774–797.  https://doi.org/10.1016/j.jmb.2007.05.022 CrossRefPubMedGoogle Scholar
  33. 33.
    Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O'Donnell-Luria AH, Vallabh Minikel E, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, , Neale BM, Daly MJ, MacArthur DG (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxivGoogle Scholar
  34. 34.
    Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526(7571):68–74.  https://doi.org/10.1038/nature15393 CrossRefGoogle Scholar
  35. 35.
    Bahler M, Rhoads A (2002) Calmodulin signaling via the IQ motif. FEBS Lett 513(1):107–113CrossRefGoogle Scholar
  36. 36.
    Tuncer GO, Teber S, Albayrak P, Kutluk MG, Deda G (2018) A case of Dravet Syndrome with a newly defined mutation in the SCN1A gene. Turk Pediatri Ars 53(4):259–262.  https://doi.org/10.5152/TurkPediatriArs.2018.4197 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Mahoney K, Moore SJ, Buckley D, Alam M, Parfrey P, Penney S, Merner N, Hodgkinson K, Young TL (2009) Variable neurologic phenotype in a GEFS+ family with a novel mutation in SCN1A. Seizure 18(7):492–497.  https://doi.org/10.1016/j.seizure.2009.04.009 CrossRefPubMedGoogle Scholar
  38. 38.
    Hoffman-Zacharska D, Szczepanik E, Terczynska I, Goszczanska-Ciuchta A, Zalewska-Miszkurka Z, Tataj R, Bal J (2015) From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit. Neurol Neurochir Pol 49(4):258–266.  https://doi.org/10.1016/j.pjnns.2015.06.006 CrossRefPubMedGoogle Scholar
  39. 39.
    Salgueiro-Pereira AR, Duprat F, Pousinha PA, Loucif A, Douchamps V, Regondi C, Ayrault M, Eugie M, Stunault MI, Escayg A, Goutagny R, Gnatkovsky V, Frassoni C, Marie H, Bethus I, Mantegazza M (2019) A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies. Neurobiol Dis 125:31–44.  https://doi.org/10.1016/j.nbd.2019.01.006 CrossRefPubMedGoogle Scholar
  40. 40.
    Jingami N, Matsumoto R, Ito H, Ishii A, Ihara Y, Hirose S, Ikeda A, Takahashi R (2014) A novel SCN1A mutation in a cytoplasmic loop in intractable juvenile myoclonic epilepsy without febrile seizures. Epileptic Disord 16(2):227–231.  https://doi.org/10.1684/epd.2014.0657 CrossRefPubMedGoogle Scholar
  41. 41.
    Escayg A, Goldin AL (2010) Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 51(9):1650–1658.  https://doi.org/10.1111/j.1528-1167.2010.02640.x CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26(1):13–25CrossRefGoogle Scholar
  43. 43.
    Spampanato J, Kearney JA, de Haan G, McEwen DP, Escayg A, Aradi I, MacDonald BT, Levin SI, Soltesz I, Benna P, Montalenti E, Isom LL, Goldin AL, Meisler MH (2004) A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J Neurosci 24(44):10022–10034.  https://doi.org/10.1523/JNEUROSCI.2034-04.2004 CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Rusconi R, Combi R, Cestele S, Grioni D, Franceschetti S, Dalpra L, Mantegazza M (2009) A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies? Hum Mutat 30(7):E747–E760.  https://doi.org/10.1002/humu.21041 CrossRefPubMedGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Division of Neurology, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia
  2. 2.Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of ScienceUniversity of MalayaKuala LumpurMalaysia
  3. 3.Cancer Precision Medicine CenterJapanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations